$PPSI
Pioneer Power Solutions Inc Stock $ppsi

$ppsi Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-K Financial Statement

#000149315224029269 Filed on July 26, 2024

Income Statement

Concept	2024 Q3	2023 Q4	2023
Revenue		$8.413M	$41.49M
YoY Change		-11.67%	53.68%
Cost Of Revenue		$8.698M	$33.14M
YoY Change		28.59%	48.01%
Gross Profit		-$285.0K	$8.350M
YoY Change		-110.33%	81.25%
Gross Profit Margin		-3.39%	20.12%
Selling, General & Admin		$2.115M	$10.12M
YoY Change		5.75%	17.17%
% of Gross Profit			121.19%
Research & Development		$885.0K	$885.0K
YoY Change
% of Gross Profit			10.6%
Depreciation & Amortization		$82.00K	$397.0K
YoY Change		-53.41%	-14.81%
% of Gross Profit			4.75%
Operating Expenses		$3.000M	$11.00M
YoY Change		50.0%	27.42%
Operating Profit		-$3.285M	-$2.654M
YoY Change		-532.24%	-34.13%
Interest Expense		$40.00K	$232.0K
YoY Change		-72.22%	-50.11%
% of Operating Profit
Other Income/Expense, Net		$520.0K	$524.0K
YoY Change		1081.82%	-882.09%
Pretax Income		-$2.725M	-$1.898M
YoY Change		-387.45%	-47.73%
Income Tax		$0.00
% Of Pretax Income
Net Earnings		-$2.725M	-$1.898M
YoY Change		-387.45%	-47.83%
Net Earnings / Revenue		-32.39%	-4.57%
Basic Earnings Per Share			-$0.19
Diluted Earnings Per Share		-$0.27	-$0.19
COMMON SHARES
Basic Shares Outstanding	10.92M shares	9.930M shares	9.905M shares
Diluted Shares Outstanding			9.905M shares

Balance Sheet

Concept	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.582M	$3.582M
YoY Change	-65.21%	-65.21%
Cash & Equivalents	$3.582M	$3.582M
Short-Term Investments
Other Short-Term Assets	$7.512M	$7.512M
YoY Change	163.3%	163.3%
Inventory	$7.579M	$7.579M
Prepaid Expenses
Receivables	$9.010M	$9.010M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$27.68M	$27.68M
YoY Change	-16.2%	-16.2%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.899M	$5.062M
YoY Change	-1.96%	27.28%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$82.00K	$277.0K
YoY Change	-49.38%	70.99%
Total Long-Term Assets	$5.339M	$5.339M
YoY Change	28.99%	28.99%
TOTAL ASSETS
Total Short-Term Assets	$27.68M	$27.68M
Total Long-Term Assets	$5.339M	$5.339M
Total Assets	$33.02M	$33.02M
YoY Change	-11.17%	-11.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.396M	$12.32M
YoY Change	-34.96%	48.43%
Accrued Expenses	$7.213M	$876.0K
YoY Change	344.15%	24.61%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$139.0K	$139.0K
YoY Change	-60.85%	-60.85%
Total Short-Term Liabilities	$18.26M	$18.26M
YoY Change	-3.69%	-3.69%
LONG-TERM LIABILITIES
Long-Term Debt	$278.0K	$278.0K
YoY Change	-33.49%	-33.49%
Other Long-Term Liabilities	$49.00K	$264.0K
YoY Change	-96.17%	-79.38%
Total Long-Term Liabilities	$49.00K	$542.0K
YoY Change	-96.17%	-57.66%
TOTAL LIABILITIES
Total Short-Term Liabilities	$18.26M	$18.26M
Total Long-Term Liabilities	$49.00K	$542.0K
Total Liabilities	$18.80M	$18.80M
YoY Change	-7.1%	-7.1%
SHAREHOLDERS EQUITY
Retained Earnings	-$19.63M
YoY Change	23.07%
Common Stock	$10.00K
YoY Change	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$14.22M	$14.22M
YoY Change
Total Liabilities & Shareholders Equity	$33.02M	$33.02M
YoY Change	-11.17%	-11.17%

Cashflow Statement

Concept	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$2.725M	-$1.898M
YoY Change	-387.45%	-47.83%
Depreciation, Depletion And Amortization	$82.00K	$397.0K
YoY Change	-53.41%	-14.81%
Cash From Operating Activities	-$3.667M	-$3.895M
YoY Change	114.44%	-31.01%
INVESTING ACTIVITIES
Capital Expenditures	$151.0K	$2.496M
YoY Change	-86.53%	65.08%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$151.0K	-$2.496M
YoY Change	-102.95%	-152.86%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$177.0K
YoY Change		941.18%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-181.0K	-$323.0K
YoY Change	-42.9%	-32.57%
NET CHANGE
Cash From Operating Activities	-3.667M	-$3.895M
Cash From Investing Activities	-151.0K	-$2.496M
Cash From Financing Activities	-181.0K	-$323.0K
Net Change In Cash	-3.999M	-$6.714M
YoY Change	-229.59%	378.55%
FREE CASH FLOW
Cash From Operating Activities	-$3.667M	-$3.895M
Capital Expenditures	$151.0K	$2.496M
Free Cash Flow	-$3.818M	-$6.391M
YoY Change	34.86%	-10.72%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	us-gaap	Payments Of Distributions To Affiliates PaymentsOfDistributionsToAffiliates		usd
CY2022Q4	PPSI	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Unvested Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsUnvestedFairValue	1087000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	100000	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	5.75
CY2023	PPSI	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Granted Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedFairValue	575000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	225000	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	4.97
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	1119000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	125000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	4.35
CY2023Q4	PPSI	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Unvested Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsUnvestedFairValue	543000	usd
CY2023	PPSI	Stock Issued During Period Shares Issued For Services Fair Value StockIssuedDuringPeriodSharesIssuedForServicesFairValue	10000	shares
CY2023	PPSI	Stock Issued During Period Value Issued For Services Fair Value StockIssuedDuringPeriodValueIssuedForServicesFairValue	65000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	1471000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	1002000	usd
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	413000	usd
CY2023	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y1M6D
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-1898000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-5412000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1898000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5412000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	7000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7000	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-399000	usd
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001449792
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q4	us-gaap	Deferred Costs DeferredCosts		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax		usd
CY2023	PPSI	Amortization Of Imputed Interest AmortizationOfImputedInterest		usd
CY2022	us-gaap	Other Noncash Income OtherNoncashIncome		usd
CY2023	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable		usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2022	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts		usd
CY2023	PPSI	Acquisition Of Right Of Use Assets And Lease Liabilities AcquisitionOfRightOfUseAssetsAndLeaseLiabilities		usd
CY2022	PPSI	Surrender And Retirement Of Common Stock SurrenderAndRetirementOfCommonStock		usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability		usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive		usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod		shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
CY2023	PPSI	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedFairValue		usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes		usd
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q4	PPSI	Net Noncurrent Deferred Income Tax Asset NetNoncurrentDeferredIncomeTaxAsset		usd
CY2022Q4	PPSI	Net Noncurrent Deferred Income Tax Asset NetNoncurrentDeferredIncomeTaxAsset		usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2023Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment		usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther		usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2023	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements		shares
CY2022	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements		shares
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-35212
CY2023	dei	Entity Registrant Name EntityRegistrantName	PIONEER POWER SOLUTIONS, INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	27-1347616
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	400 Kelby Street
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	12th Floor
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Fort Lee
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	NJ
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	07024
CY2023	dei	City Area Code CityAreaCode	(212)
CY2023	dei	Local Phone Number LocalPhoneNumber	867-0700
CY2023	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
CY2023	dei	Trading Symbol TradingSymbol	PPSI
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	63848	usd
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	10917038	shares
CY2023	dei	Auditor Firm AuditorFirmId	688
CY2023	dei	Auditor Name AuditorName	Marcum LLP
CY2023	dei	Auditor Location AuditorLocation	Saddle Brook, NJ
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	41493000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	25878000	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	33143000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	23052000	usd
CY2023	us-gaap	Gross Profit GrossProfit	8350000	usd
CY2022	us-gaap	Gross Profit GrossProfit	2826000	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	10119000	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	8636000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	885000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	11004000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	8636000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-2654000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-5810000	usd
CY2023	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	232000	usd
CY2022	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	465000	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	524000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-67000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1898000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5412000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-1898000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-5419000	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.19
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.56
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.19
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.56
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9905234	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9727542	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9905234	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9727542	shares
CY2023Q4	us-gaap	Cash Cash	3582000	usd
CY2022Q4	us-gaap	Cash Cash	10296000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	97000	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-1136000	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	6000	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	-7000	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	-2000	usd
CY2023	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	28000	usd
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	153000	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	378000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1010000	usd
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-24000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7000	usd
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.001	pure
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	788000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	9010000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	10010000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	7579000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	8090000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7512000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2853000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	27683000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	31249000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3899000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1800000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	760000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1450000	usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	403000	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	727000	usd
CY2023Q4	us-gaap	Deferred Costs DeferredCosts	195000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	82000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	162000	usd
CY2023Q4	us-gaap	Assets Assets	33022000	usd
CY2022Q4	us-gaap	Assets Assets	35388000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	12609000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	7239000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	582000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	703000	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	139000	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	355000	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	4932000	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	10659000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	18262000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	18956000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	215000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	797000	usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	278000	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	418000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	49000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	65000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	18804000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	20236000	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9930022	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9930022	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9644545	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9644545	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	10000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	10000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	33837000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	32859000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	14000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-19629000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-17731000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	14218000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	15152000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	33022000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	35388000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-1898000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-5419000	usd
CY2023	us-gaap	Depreciation Depreciation	397000	usd
CY2022	us-gaap	Depreciation Depreciation	228000	usd
CY2023	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	324000	usd
CY2022	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	238000	usd
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	690000	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	663000	usd
CY2022	PPSI	Amortization Of Imputed Interest AmortizationOfImputedInterest	-455000	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	97000	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-140000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	1471000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	1002000	usd
CY2023	us-gaap	Other Noncash Income OtherNoncashIncome	14000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-585000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	7441000	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-511000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3931000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4982000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1799000	usd
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-7000	usd
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	28000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	5361000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	3670000	usd
CY2023	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-5727000	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	8237000	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-703000	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-653000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3895000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5772000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2496000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1512000	usd
CY2022	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	6234000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2496000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	4722000	usd
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	50000	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	17000	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	177000	usd
CY2022	us-gaap	Payments Of Distributions To Affiliates PaymentsOfDistributionsToAffiliates	129000	usd
CY2023	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	195000	usd
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	355000	usd
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	241000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-323000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-353000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-6714000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1403000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	10296000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	11699000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3582000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	10296000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	7000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	4000	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-20000	usd
CY2022	PPSI	Acquisition Of Right Of Use Assets And Lease Liabilities AcquisitionOfRightOfUseAssetsAndLeaseLiabilities	841000	usd
CY2023	PPSI	Surrender And Retirement Of Common Stock SurrenderAndRetirementOfCommonStock	720000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	19552000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-5419000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1002000	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	17000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	15152000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-1898000	usd
CY2023	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	1471000	usd
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	50000	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	177000	usd
CY2023	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	720000	usd
CY2023	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	-14000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	14218000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	14218000	usd
CY2023	PPSI	Number Of Additional Locations NumberOfAdditionalLocations	3	location
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segments
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3582000	usd
CY2023Q4	PPSI	Working Capital Deficit WorkingCapitalDeficit	9421000	usd
CY2022Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	7500000	usd
CY2023	PPSI	Public Float Heldby Non Affiliates PublicFloatHeldbyNonAffiliates	75000000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	10010000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	8090000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	31249000	usd
CY2022Q4	us-gaap	Assets Assets	35388000	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	10659000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	18956000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	20236000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-17731000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	15152000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	35388000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	25878000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	23052000	usd
CY2022	us-gaap	Gross Profit GrossProfit	2826000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-5810000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5412000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-5419000	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.56
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.56
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	19552000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-5419000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	15152000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-5419000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	7441000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3931000	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	8237000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5772000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84F_eus-gaap--UseOfEstimates_z9hjHU935JWb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_862_zkB9BhKEIzxc">Use of Estimates</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 29.7pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. The consolidated financial statements include estimates based on currently available information and management’s judgment as to the outcome of future conditions and circumstances. Significant estimates in these consolidated financial statements include, but are not limited to, measurement of revenue for contracts accounted for over time, accounts receivable reserves, inventory valuation, useful lives and impairment of long-lived assets, stock-based compensation and the valuation allowance related to the Company’s deferred tax assets. Changes in the status of certain facts or circumstances could result in material changes to the estimates used in the preparation of the consolidated financial statements and actual results could differ from the estimates and assumptions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_845_eus-gaap--ConcentrationRiskCreditRisk_z2dDuQuLMXqa" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Concentrations</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company manages its accounts receivable credit risk by performing credit evaluations and monitoring amounts due from the Company’s customers. The Company had certain customers whose revenue individually represented 10% or more of the Company’s total revenue, or whose accounts receivable balances individually represented 10% or more of the Company’s total accounts receivable, as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">At December 31, 2023, one customer represented approximately <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zTSMZe2oqjB">23</span>% of the Company’s accounts receivable. At December 31, 2022, three customers represented approximately <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomertOneMember_zXP39QCi3We9">52</span>%, <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomertTwoMember_zTJXwL2TRJL1">15</span>% and <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zGX9myNfIkke">12</span>% of the Company’s accounts receivable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: justify">For the year ended December 31, 2023, two customers represented approximately <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zLESjek6p2Fl" title="Concentration percentage">42</span>% and <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zcqx5SKQ66Zk" title="Concentration percentage">20</span>% of the Company’s revenue. For the year ended December 31, 2022, two customers represented approximately <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zBdgOMqtJPki" title="Concentration percentage">43</span>% and <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zHufR5tKqfD" title="Concentration percentage">10</span>% of the Company’s revenue.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: justify">As of December 31, 2023, one of the Company’s suppliers represented <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierMember_zmYrgfufTM16" title="Concentration percentage">18</span>% of the Company’s accounts payable. As of December 31, 2022, three of the Company’s suppliers represented <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThreeSupplierMember_zcl2XUeyerDg" title="Concentration percentage">38</span>% of the Company’s accounts payable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p>
CY2023Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	3332000	usd
CY2022Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	10046000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	97	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	788	usd
CY2022Q1	us-gaap	Inventory Net InventoryNet	4899000	usd
CY2022Q1	us-gaap	Assets Current AssetsCurrent	30096000	usd
CY2022Q1	us-gaap	Assets Assets	32917000	usd
CY2022Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	7015000	usd
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	14416000	usd
CY2022Q1	us-gaap	Liabilities Liabilities	15842000	usd
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-14863000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	17075000	usd
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	32917000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	5103000	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	27166000	usd
CY2022Q2	us-gaap	Assets Assets	30202000	usd
CY2022Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	8448000	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	14855000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	16295000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-18690000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	13907000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	30202000	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	6630000	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	24602000	usd
CY2022Q3	us-gaap	Assets Assets	27596000	usd
CY2022Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	6562000	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	12240000	usd
CY2022Q3	us-gaap	Liabilities Liabilities	13544000	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-18689000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	14051000	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	27596000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7701000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	8502000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	30659000	usd
CY2023Q1	us-gaap	Assets Assets	34608000	usd
CY2023Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	10007000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	17526000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	18585000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-16989000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	16023000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	34608000	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6215000	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	8385000	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	26849000	usd
CY2023Q2	us-gaap	Assets Assets	31003000	usd
CY2023Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	4764000	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	12480000	usd
CY2023Q2	us-gaap	Liabilities Liabilities	13313000	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-16141000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	17690000	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	31003000	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7970000	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	9185000	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	30254000	usd
CY2023Q3	us-gaap	Assets Assets	35700000	usd
CY2023Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	5926000	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	16559000	usd
CY2023Q3	us-gaap	Liabilities Liabilities	17208000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-15130000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	18492000	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	35700000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6339000	usd
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	7227000	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	-888000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2634000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2544000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2551000	usd
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.26
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.26
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4826000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	11166000	usd
CY2022Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	6056000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	13283000	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	-1229000	usd
	us-gaap	Gross Profit GrossProfit	-2117000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-3814000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-6448000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3827000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6371000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-3827000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6378000	usd
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.39
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.39
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.65
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.65
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6369000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	17535000	usd
CY2022Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4195000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	17478000	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	2174000	usd
	us-gaap	Gross Profit GrossProfit	56000	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	2305000	usd
	us-gaap	Operating Expenses OperatingExpenses	6636000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-131000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-6580000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6370000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	2000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6377000	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.66
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10441	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10384	shares
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.61
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9555000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	6723000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	2833000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	675000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	742000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	742000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.07
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.07
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	12282000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	21838000	usd
CY2023Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	8404000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	15127000	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	3878000	usd
	us-gaap	Gross Profit GrossProfit	6711000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	789000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	1465000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	848000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1590000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	848000	usd
	us-gaap	Net Income Loss NetIncomeLoss	1590000	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.09
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.16
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10747	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10677	shares
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.08
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.15
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	11453000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	33291000	usd
CY2023Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	7756000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	22882000	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	3698000	usd
	us-gaap	Gross Profit GrossProfit	10409000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	940000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	2405000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1011000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2601000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	1011000	usd
	us-gaap	Net Income Loss NetIncomeLoss	2601000	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.10
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.10
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.26
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.26
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	19552000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2551000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	17075000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	19552000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6378000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	13907000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	19552000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6377000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	14051000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	15152000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	742000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	16023000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	15152000	usd
	us-gaap	Net Income Loss NetIncomeLoss	1590000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	17690000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	15152000	usd
	us-gaap	Net Income Loss NetIncomeLoss	2601000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	18492000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2551000	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	739000	usd
CY2022Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	4592000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2087000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6378000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	943000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	6025000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1621000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6377000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2470000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	4139000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3936000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	742000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2308000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	412000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-652000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1525000	usd
	us-gaap	Net Income Loss NetIncomeLoss	1590000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3774000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	295000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-5896000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	366000	usd
	us-gaap	Net Income Loss NetIncomeLoss	2601000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1642000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1095000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-4733000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-228000	usd
CY2022Q1	us-gaap	Deferred Revenue DeferredRevenue	2423000	usd
CY2023	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	9046000	usd
CY2022	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	2158000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	41493000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	25878000	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	5316000	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	2962000	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	2263000	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	5128000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	7579000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	8090000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6470000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3974000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2571000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2174000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3899000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1800000	usd
CY2023	us-gaap	Depreciation Depreciation	397000	usd
CY2022	us-gaap	Depreciation Depreciation	228000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5396000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5615000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7213000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1624000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	12609000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	7239000	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	5000000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	0	usd
CY2023Q4	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	442000	usd
CY2022Q4	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	278000	usd
CY2023Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	294000	usd
CY2022Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	213000	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	67000	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	258000	usd
CY2023Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	795000	usd
CY2022Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	559000	usd
CY2023	PPSI	Weighted Average Remaining Lease Extend Term WeightedAverageRemainingLeaseExtendTerm	P5Y
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	638000	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	1261000	usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset Accumulated Amortization FinanceLeaseRightOfUseAssetAccumulatedAmortization	235000	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset Accumulated Amortization FinanceLeaseRightOfUseAssetAccumulatedAmortization	534000	usd
CY2023Q4	PPSI	Operating Lease Right Of Use Asset Before Accumulated Amortization OperatingLeaseRightOfUseAssetBeforeAccumulatedAmortization	2248000	usd
CY2022Q4	PPSI	Operating Lease Right Of Use Asset Before Accumulated Amortization OperatingLeaseRightOfUseAssetBeforeAccumulatedAmortization	2248000	usd
CY2023Q4	PPSI	Operating Lease Right Of Use Asset Accumulated Amortization OperatingLeaseRightOfUseAssetAccumulatedAmortization	1488000	usd
CY2022Q4	PPSI	Operating Lease Right Of Use Asset Accumulated Amortization OperatingLeaseRightOfUseAssetAccumulatedAmortization	798000	usd
CY2022Q4	PPSI	Lease Liability After Adjusting Weighted Average Discount Rate LeaseLiabilityAfterAdjustingWeightedAverageDiscountRate	275000	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	762000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	752000	usd
CY2023	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	324000	usd
CY2022	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	238000	usd
CY2023	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	42000	usd
CY2022	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	44000	usd
CY2023	us-gaap	Lease Cost LeaseCost	366000	usd
CY2022	us-gaap	Lease Cost LeaseCost	282000	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	774000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	742000	usd
CY2023	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	42000	usd
CY2022	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	44000	usd
CY2023	PPSI	Financing Cash Flow Payments For Finance Leases FinancingCashFlowPaymentsForFinanceLeases	355000	usd
CY2022	PPSI	Financing Cash Flow Payments For Finance Leases FinancingCashFlowPaymentsForFinanceLeases	241000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	440000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	401000	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y
CY2023Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y
CY2022Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0550	pure
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0550	pure
CY2023Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0680	pure
CY2022Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0673	pure
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	613000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	166000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	200000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	174000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	24000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	88000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	41000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	837000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	469000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	40000	usd
CY2023Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	52000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	797000	usd
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	417000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	760000	usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	403000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	797000	usd
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	417000	usd
CY2023Q4	PPSI	Common Stock Adverse Party Percentage CommonStockAdversePartyPercentage	0.05	pure
CY2022Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	7500000	usd
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9930022	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9644545	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y6M
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.029	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.311	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000	pure
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	670667	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.45
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	97500	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	5.80
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	15000	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	3.31
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	47000	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	6.16
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	706167	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.49
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y6M
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1262000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	611167	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	5.45
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y10M24D
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	1147000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.97
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.09
CY2023	PPSI	Share Based Compensation Arrangement By Share Based Payment Award Options Gain Loss On Exercises In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGainLossOnExercisesInPeriodIntrinsicValue	52000	usd
CY2022	PPSI	Share Based Compensation Arrangement By Share Based Payment Award Options Gain Loss On Exercises In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGainLossOnExercisesInPeriodIntrinsicValue	-6000	usd
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	50000	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	17000	usd
CY2023Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	706167	shares
CY2023Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	611167	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	250000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	4.35
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	89000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	59000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	89000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	59000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	4930000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	4048000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	1874000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	1530000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	4272000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	4300000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	29000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	1391000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	1516000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	12378000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	11365000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	89000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	59000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	89000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	53000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	6000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	89000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	59000	usd
CY2023Q4	PPSI	Federal Operating Loss Carryforwards FederalOperatingLossCarryforwards	18228000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.80	pure
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	12467000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	12378000	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	1013000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	39000	usd
CY2023Q4	us-gaap	Tax Credit Carryforward Amount TaxCreditCarryforwardAmount	2897000	usd
CY2023	us-gaap	Revenues Revenues	41493000	usd
CY2022	us-gaap	Revenues Revenues	25878000	usd
CY2023	us-gaap	Revenues Revenues	41493000	usd
CY2022	us-gaap	Revenues Revenues	25878000	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	721000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	466000	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	721000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	466000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-2654000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-5810000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-2654000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-5810000	usd
CY2023Q4	us-gaap	Assets Assets	33022000	usd
CY2022Q4	us-gaap	Assets Assets	35388000	usd
CY2023Q4	us-gaap	Assets Assets	33022000	usd
CY2022Q4	us-gaap	Assets Assets	35388000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-1898000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-5419000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9905234	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9727542	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9905234	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9727542	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.19
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.56
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.19
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.56

Files In Submission

Name	View Source	Status
0001493152-24-029269-index-headers.html	Edgar Link	pending
0001493152-24-029269-index.html	Edgar Link	pending
0001493152-24-029269.txt	Edgar Link	pending
0001493152-24-029269-xbrl.zip	Edgar Link	pending
ex23-1.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
ex4-1.htm	Edgar Link	pending
ex97-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
form10-k_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
ppsi-20231231.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
ppsi-20231231_cal.xml	Edgar Link	unprocessable
ppsi-20231231_def.xml	Edgar Link	unprocessable
ppsi-20231231_lab.xml	Edgar Link	unprocessable
ppsi-20231231_pre.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PPSI
Pioneer Power Solutions Inc Stock $ppsi

2024 Q3 Form 10-K Financial Statement

#000149315224029269 Filed on July 26, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PPSI Pioneer Power Solutions Inc Stock $ppsi

2024 Q3 Form 10-K Financial Statement

#000149315224029269 Filed on July 26, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PPSI
Pioneer Power Solutions Inc Stock $ppsi